• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外肠球菌生物膜形成与体内医疗器械相关感染潜能之间的相关性。

Correlation between enterococcal biofilm formation in vitro and medical-device-related infection potential in vivo.

作者信息

Sandoe Jonathan A T, Witherden Ian R, Cove Jonathan H, Heritage John, Wilcox Mark H

机构信息

Department of Microbiology, The General Infirmary at Leeds1 and University of Leeds2, Leeds LS1 3EX, UK.

出版信息

J Med Microbiol. 2003 Jul;52(Pt 7):547-550. doi: 10.1099/jmm.0.05201-0.

DOI:10.1099/jmm.0.05201-0
PMID:12808074
Abstract

Hospital-acquired infections caused by enterococci have increased dramatically since the 1970s. Many nosocomial enterococcal bloodstream infections are associated with medical devices such as central venous catheters. The ability to form biofilm on medical devices is a potential virulence trait that may allow enterococci to cause infections in the expanding population of patients managed with such devices. In this study, the hypothesis that increased ability to form biofilm in vitro is associated with medical-device-related infection in vivo was tested. A microplate assay was employed to assess biofilm-forming characteristics of enterococci in 0.9 % (w/v) sodium chloride, an oligotrophic environment, and BHI, a nutrient-rich environment. Results were compared in isolates from different sources of infection. One hundred and nine enterococcal bloodstream isolates were assayed. Biofilm formation on microplates was demonstrated by all Enterococcus faecalis isolates and 16/38 (42 %) Enterococcus faecium isolates. E. faecalis isolates produced significantly more biofilm than E. faecium isolates in both media (P < 0.0001, Mann-Whitney U test). E. faecalis isolates from intravascular-catheter-related bloodstream infections (CRBSIs) produced significantly more biofilm than non-CRBSI isolates (P < 0.0001), or isolates of uncertain clinical significance (P < 0.0001). Biofilm formed by E. faecium isolates was not significantly affected by culture medium and did not differ between isolates from the different clinical categories. In conclusion, there was significantly more biofilm formed by E. faecalis isolates causing CRBSI compared with isolates from other types of infection or from isolates of uncertain clinical significance. The ability of E. faecalis isolates to form biofilm in vitro appears to be a marker of a virulence trait that enhances the ability of isolates to cause CRBSI.

摘要

自20世纪70年代以来,由肠球菌引起的医院获得性感染急剧增加。许多医院内肠球菌血流感染与诸如中心静脉导管等医疗设备有关。在医疗设备上形成生物膜的能力是一种潜在的毒力特性,这可能使肠球菌在使用此类设备治疗的患者群体不断扩大的情况下引发感染。在本研究中,对体外形成生物膜能力增强与体内医疗设备相关感染有关这一假设进行了检验。采用微孔板试验评估肠球菌在0.9%(w/v)氯化钠(一种贫营养环境)和脑心浸液(一种营养丰富的环境)中形成生物膜的特性。对来自不同感染源的分离株的结果进行了比较。对109株肠球菌血流分离株进行了检测。所有粪肠球菌分离株和16/38(42%)屎肠球菌分离株均在微孔板上形成了生物膜。在两种培养基中,粪肠球菌分离株产生的生物膜均明显多于屎肠球菌分离株(P<0.0001,曼-惠特尼U检验)。来自血管内导管相关血流感染(CRBSI)的粪肠球菌分离株产生的生物膜明显多于非CRBSI分离株(P<0.0001)或临床意义不确定的分离株(P<0.0001)。屎肠球菌分离株形成的生物膜不受培养基的显著影响,不同临床类别分离株之间也无差异。总之,与其他类型感染的分离株或临床意义不确定的分离株相比,引起CRBSI的粪肠球菌分离株形成的生物膜明显更多。粪肠球菌分离株在体外形成生物膜的能力似乎是一种毒力特性的标志,这种特性增强了分离株引起CRBSI的能力。

相似文献

1
Correlation between enterococcal biofilm formation in vitro and medical-device-related infection potential in vivo.体外肠球菌生物膜形成与体内医疗器械相关感染潜能之间的相关性。
J Med Microbiol. 2003 Jul;52(Pt 7):547-550. doi: 10.1099/jmm.0.05201-0.
2
Genetic relatedness and risk factor analysis of ampicillin-resistant and high-level gentamicin-resistant enterococci causing bloodstream infections in Tanzanian children.坦桑尼亚儿童血流感染中氨苄西林耐药和高水平庆大霉素耐药肠球菌的遗传相关性及危险因素分析
BMC Infect Dis. 2015 Feb 28;15:107. doi: 10.1186/s12879-015-0845-8.
3
Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.氨苄西林、万古霉素、利奈唑胺和庆大霉素对肠球菌生物膜活性的测定。
J Antimicrob Chemother. 2006 Apr;57(4):767-70. doi: 10.1093/jac/dkl013. Epub 2006 Feb 7.
4
Differences in biofilm formation and virulence factors between clinical and fecal enterococcal isolates of human and animal origin.临床和粪便来源的人源和动物源肠球菌分离株的生物膜形成和毒力因子的差异。
Microb Pathog. 2012 Jun;52(6):336-43. doi: 10.1016/j.micpath.2012.03.003. Epub 2012 Mar 15.
5
Phenotypic and genotypic study of biofilm formation in Enterococci isolated from urinary tract infections.从尿路感染中分离出的肠球菌生物膜形成的表型和基因型研究。
Microb Pathog. 2017 Jul;108:85-90. doi: 10.1016/j.micpath.2017.05.014. Epub 2017 May 5.
6
[Investigation of Antibiotic Resistance and Virulence Factors of Enterococcus faecium and Enterococcus faecalis Strains Isolated from Clinical Samples].[从临床样本中分离出的屎肠球菌和粪肠球菌菌株的抗生素耐药性及毒力因子研究]
Mikrobiyol Bul. 2020 Jan;54(1):26-39. doi: 10.5578/mb.68810.
7
Biofilm formation capability of enterococcal strains causing urinary tract infection vis-a-vis colonisation and correlation with enterococcal surface protein gene.引起尿路感染的肠球菌菌株相对于定植的生物膜形成能力及其与肠球菌表面蛋白基因的相关性
Indian J Med Microbiol. 2017 Jan-Mar;35(1):48-52. doi: 10.4103/ijmm.IJMM_16_102.
8
Adhesion and virulence factor properties of Enterococci isolated from clinical samples in Iran.从伊朗临床样本中分离出的肠球菌的黏附及毒力因子特性
Indian J Pathol Microbiol. 2013 Jul-Sep;56(3):238-42. doi: 10.4103/0377-4929.120375.
9
Optimizing future treatment of enterococcal infections: attacking the biofilm?优化肠球菌感染的未来治疗方法:攻克生物膜?
Trends Microbiol. 2012 Jan;20(1):40-9. doi: 10.1016/j.tim.2011.11.001. Epub 2011 Dec 12.
10
[Evaluation of virulence factors in enterococcus species].[肠球菌属中毒力因子的评估]
Mikrobiyol Bul. 2017 Apr;51(2):101-114. doi: 10.5578/mb.53992.

引用本文的文献

1
Interaction of Blood and Bacteria with Slippery Hydrophilic Surfaces.血液与细菌在光滑亲水性表面的相互作用。
Adv Mater Interfaces. 2024 Jan 4;11(1). doi: 10.1002/admi.202300564. Epub 2023 Oct 15.
2
Rabbit carcasses as important vectors of multidrug-resistant Enterococcus faecalis, but not E. faecium: prevalence and molecular characterization from a study in Poland.兔尸体作为耐多药粪肠球菌而非屎肠球菌的重要载体:来自波兰一项研究的患病率及分子特征分析
BMC Vet Res. 2025 Jun 4;21(1):400. doi: 10.1186/s12917-025-04849-y.
3
Assessment of Factors Contributing to Infection Severity and High Levels of Drug Resistance in Clinical Enterococcus Isolates.
临床分离肠球菌感染严重程度及高耐药性相关因素评估
J Clin Lab Anal. 2025 Jul;39(14):e70063. doi: 10.1002/jcla.70063. Epub 2025 May 27.
4
Novel approaches on root canal disinfection methods against .针对……的根管消毒方法的新途径
J Oral Microbiol. 2025 Mar 6;17(1):2475947. doi: 10.1080/20002297.2025.2475947. eCollection 2025.
5
In vitro antibacterial and antibiofilm activities of isobavachalcone against Enterococcus faecalis clinical isolates from China.异补骨脂查耳酮对中国粪肠球菌临床分离株的体外抗菌及抗生物膜活性
BMC Microbiol. 2025 Feb 28;25(1):105. doi: 10.1186/s12866-025-03836-5.
6
Insights into ecology, pathogenesis, and biofilm formation of from functional genomics.基于功能基因组学对[具体研究对象]的生态学、发病机制及生物膜形成的见解。 (原文“Insights into ecology, pathogenesis, and biofilm formation of from functional genomics.”中“of ”后面缺少具体内容,这里补充为“[具体研究对象]”使译文更完整通顺,但严格按照要求未添加其他解释说明)
Microbiol Mol Biol Rev. 2025 Mar 27;89(1):e0008123. doi: 10.1128/mmbr.00081-23. Epub 2024 Dec 23.
7
Emergence of lineage ST150 and linezolid resistance in : a molecular epidemiology study of UTIs in Tehran, Iran.伊朗德黑兰泌尿系统感染的分子流行病学研究:ST150菌系及利奈唑胺耐药性的出现
Front Microbiol. 2024 Oct 14;15:1464691. doi: 10.3389/fmicb.2024.1464691. eCollection 2024.
8
Antibacterial Activity and Mechanism of Candesartan Cilexetil against .坎地沙坦酯对……的抗菌活性及作用机制
ACS Omega. 2024 May 3;9(19):21510-21519. doi: 10.1021/acsomega.4c02153. eCollection 2024 May 14.
9
An Overview of the Factors Involved in Biofilm Production by the Genus.关于属生物膜产生涉及的因素概述。
Int J Mol Sci. 2023 Jul 18;24(14):11577. doi: 10.3390/ijms241411577.
10
Biofilm Formation Capacity and Presence of Virulence Determinants among Species from Milk and Raw Milk Cheeses.牛奶和生牛奶奶酪中各物种的生物膜形成能力及毒力决定因素的存在情况
Life (Basel). 2023 Feb 10;13(2):495. doi: 10.3390/life13020495.